Digital Health Brazil

Brazil Disease Surveillance Systems Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Brazil Disease Surveillance Systems Market Industry Trends and Forecast to 2034: Segmented by (Type, User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Brazil · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $213.9 Mn Placeholder estimate
Estimate 2025 $233.4 Mn 2.9% of the global market
Projected 2034 $511.2 Mn 119% Adds $277.7 Mn over 9 forecast years
CAGR 2025–2034 9.1% Faster than 10% of 100 Digital Health markets here
Key players 5 Companies profiled
  • Brazil is 2.86% of the global market.
  • In Latin America, the largest is Brazil (this report) at $233.4 Mn.
  • Fastest growing: Brazil (this report) at 9.1% a year.
  • Brazil ranks 1st of 3 by size in Latin America.

Market size projection

Brazil

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$277.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Disease Surveillance Systems Market market size by year, Brazil
YearMarket sizeChange that yearSince 2025
2024 (estimate) $213.9 Mn — —
2025 (base) $233.4 Mn +$19.5 Mn —
2026 (forecast) $254.7 Mn +$21.2 Mn +9.1%
2027 (forecast) $277.8 Mn +$23.2 Mn +19%
2028 (forecast) $303.1 Mn +$25.3 Mn +29.9%
2029 (forecast) $330.7 Mn +$27.6 Mn +41.7%
2030 (forecast) $360.8 Mn +$30.1 Mn +54.6%
2031 (forecast) $393.6 Mn +$32.8 Mn +68.6%
2032 (forecast) $429.4 Mn +$35.8 Mn +84%
2033 (forecast) $468.5 Mn +$39.1 Mn +100.7%
2034 (forecast) $511.2 Mn +$42.6 Mn +119%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Brazil Disease Surveillance Systems Market Analysis at a glance
Market size, 2025$233.4 Mn placeholder estimate
Forecast, 2034$511.2 Mn placeholder estimate
Growth (CAGR), 2025–20349.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType and user (see all)
Key playersSAS Institute, Biobot Analytics, Ginkgo Bioworks, BlueDot, Esri (see all)
Regulator in BrazilANVISASource: ANVISA. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Brazil Disease Surveillance Systems Market Analysis Executive Summary

Disease surveillance systems collect and analyse data to spot outbreaks early and guide public health action.

Key segments of the disease Surveillance Systems market include type (Syndromic Surveillance, Lab-Based Surveillance and Genomic Surveillance) and user (Governments, WHO and NGOs and Hospitals).

Bar chart: Brazil Disease Surveillance Systems market size, 2024–2034, placeholder estimates. $213.9 Mn in 2024, $233.4 Mn in 2025 and $511.2 Mn in 2034, 9.1% CAGR.
Brazil Disease Surveillance Systems market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Brazil Disease Surveillance Systems Market Dynamics

Market Growth Drivers

Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the disease Surveillance Systems market.

Opportunity

Digital tools for community health, local manufacturing and public-private partnerships give the disease Surveillance Systems market room to grow.

Market Restraints

Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the disease Surveillance Systems market.

Competitive Landscape for Disease Surveillance Systems Market in Brazil

The disease Surveillance Systems market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Disease Surveillance Systems Market in Brazil

Disease Surveillance Systems in Brazil: rules and payment

Software used for diagnosis or treatment is regulated by ANVISA, the National Health Surveillance Agency, as a medical device.⁠[1] The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds.⁠[2]

[1] ANVISA. Checked 14 Nov 2026.

[2] CONITEC. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the disease Surveillance Systems market. Government digital health programs in Brazil are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Disease Surveillance Systems right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Disease Surveillance Systems in context

Brazil compared

  • Health spending per person: 1,010 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 7 countries we cover in Latin America.[1]
  • Doctors: 2.36 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 5th highest of the 7 countries we cover in Latin America.[2]
  • People aged 65 and over: 11.5% of people (2025). World: 10.4% of people (2025). 3rd highest of the 7 countries we cover in Latin America.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Disease Surveillance Systems market in Brazil?
Placeholder estimate: about $233.4 Mn in 2025, rising to about $511.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Disease Surveillance Systems market in Brazil growing?
Placeholder estimate: about 9.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Disease Surveillance Systems market report cover?
The report splits the market by type (Syndromic Surveillance, Lab-Based Surveillance, Genomic Surveillance, Wastewater Surveillance) and user (Governments, WHO and NGOs, Hospitals).
Who are the key players in the Disease Surveillance Systems market?
Key players include SAS Institute, Biobot Analytics, Ginkgo Bioworks, BlueDot and Esri.
What is driving the Disease Surveillance Systems market?
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the disease Surveillance Systems market.
Who regulates Disease Surveillance Systems in Brazil?
Software used for diagnosis or treatment is regulated by ANVISA, the National Health Surveillance Agency, as a medical device. Source: ANVISA. Checked 14 Nov 2026.
How is healthcare paid for in Brazil?
The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds. Source: CONITEC. Checked 14 Nov 2026.
How much research is published on Disease Surveillance Systems?
PubMed lists 172 papers on Disease Surveillance Systems added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in Brazil

See all

Related on infectious diseases and health it and data

See the topic